Long-term efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: 104-week VERTIS MET trial.
Long-term efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: 104-week VERTIS MET trial. — المؤلف: Gallo, Silvina — Diabetes, obesity & metabolism 20200907
- المؤلف
- Gallo, Silvina
- النشر
- Diabetes, obesity & metabolism 20200907
- الوصف
- 1027-1036 p.
- الموضوعات
- Aged؛ Blood Glucose؛ Bone Density؛ Bridged Bicyclo Compounds, Heterocyclic؛ Diabetes Mellitus, Type 2؛ Double-Blind Method؛ Female؛ Glycated Hemoglobin